A systematic literature review from 1998 to 2003 showed that few cost-effectiveness analyses of self-administered medications model suboptimal medication adherence.
Jennifer A. Palmer, MS
Advertisement
Articles by Jennifer A. Palmer, MS
A panel composed of medical and pharmacy directors expressed strong support for a greater role for cost-effectiveness analysis in US health policy decisions.
Advertisement
Latest Updated Articles
- Patient Adherence: A Blind Spot in Cost-Effectiveness Analyses?
September 7th 2009
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
3
Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care
4
FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies
5